| CAS NO: | 614-39-1 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5g | 电议 |
| 10g | 电议 |
| 25g | 电议 |
| Molecular Weight (MW) | 271.79 |
|---|---|
| Formula | C13H22ClN3O |
| CAS No. | 614-39-1 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility (In vitro) | DMSO: 54 mg/mL (198.6 mM) |
| Water: N/A | |
| Ethanol: 54 mg/mL (198.6 mM) | |
| Other info | Chemical Name: 4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride InChi Key: ABTXGJFUQRCPNH-UHFFFAOYSA-N InChi Code: InChI=1S/C13H21N3O.ClH/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11;/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17);1H SMILES Code: CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl |
| Synonyms | Pronestyl; Procainamide HCl; Procanbid; Procaine Amide; Procan; Procapan; Procainamide Hydrochloride; Procamide; Pronestyl; Procan SR; Procanbid; |
| In Vitro | In vitro activity: Procainamide hydrochloride is an anti-arrhythmic agent and is used to treat cardiac arrhythmia; induces rapid block of the batrachotoxin(BTX)-activated sodium channels of the heart muscle and acts as antagonist to long gating closures. |
|---|---|
| In Vivo | |
| Animal model | |
| Formulation & Dosage | |
| References | Zamponi GW, et al. Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation. Biophys J. 1993 Dec;65(6):2324-34. |
m.cnreagent.com